focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChamberlin Plc Regulatory News (CMH)

  • This share is currently suspended. It was suspended at a price of 1.18

Share Price Information for Chamberlin Plc (CMH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.18
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1.18
CMH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

10 Apr 2024 07:00

RNS Number : 9300J
Chamberlin PLC
10 April 2024
 

10 April 2024

 

Chamberlin plc

("Chamberlin", the "Company" or the "Group")

 

Trading Update

 

Chamberlin plc (AIM: CMH.L), the specialist castings and machining group, announces a trading update in respect of the three-month period ending 29 February 2024 ("Q3 FY24") and outlook for the final quarter of FY24 ending 31 May 2024 ("Q4 FY24").

 

Underlying demand across the Group during Q3 FY24 was below management's expectations. Schedules over the period were lower than previously forecast by our customers and were further impacted by delays with the startup of certain new programs. Encouragingly, demand from customers in the renewable offshore energy market remained very strong, but the majority of other market sectors were affected by a slowdown in immediate demand.

 

Lower sales during Q3 FY24 have negatively affected profitability and working capital, however the management team are taking appropriate action to mitigate the impact now and going forward.

 

The slowdown has started to improve during Q4 FY24 and customer schedules are recovering to a more normalised and stable level, with a strong uptick in demand forecast within the next 6-month period as new programs start to ramp up production.

 

Following a full strategic review, a program of cost reduction actions have been implemented across the Group including labour reductions, short time working (as required) and senior management restructuring. Alongside this, the Company has conducted a full review of product margins and implemented price increases accordingly to underpin the required profitability and cash generation. The Group is expected to benefit from these actions within 3 months and create a more robust level of profitability going forward.

 

As previously announced, balance sheet debt following the sale of Petrel Ltd has greatly improved and the Company remains focused on paying off the remainder of its legacy debt within the next 12-month period (excluding the remaining pension deficit and HSBC invoice finance facility). Working capital levels are being monitored closely following recent performance and the steps being taken by the management team are expected to improve this position going forward.

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 as it forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018.

 

Enquiries:

 

Chamberlin plc

Kevin Price, Chief Executive

Alan Tomlinson, Finance Director

 

 

T: 01922 707100

Cavendish Capital Markets Limited

(Nominated Adviser and Joint Broker)

Katy Birkin

Stephen Keys

George Lawson

 

 

T: 020 7220 5500

Peterhouse Capital Limited

(Joint Broker)

Lucy Williams

Duncan Vasey

T: 020 7469 0930

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUPUBCCUPCGQB
Date   Source Headline
13th Apr 20115:50 pmRNSTrading Update
12th Apr 20113:51 pmRNSHolding(s) in Company
4th Feb 20117:00 amRNSAcquisition
15th Dec 20102:06 pmRNSHolding(s) in Company
24th Nov 20107:00 amRNSHalf Year Results
26th Oct 20107:00 amRNSMajor Contract Win
26th Oct 20107:00 amRNSMajor Contract Win
24th Sep 20107:00 amRNSPre close Trading Update
13th Sep 20101:30 pmRNSDirector/PDMR Shareholding
29th Jul 20103:24 pmRNSResult of AGM
29th Jul 20107:00 amRNSAGM Statement
13th Jul 20107:00 amRNSDirector/PDMR Shareholding
9th Jul 20107:00 amRNSDirector's Share Dealing
28th Jun 20107:00 amRNSDirector Share Dealing
16th Jun 201010:58 amRNSRe: Applicable Employee
14th Jun 20103:28 pmRNSDirector/PDMR Shareholding
10th Jun 20107:00 amRNSFinal Results
18th May 201012:22 pmRNSBoard Change
15th Mar 201011:41 amRNSDirector/PDMR Shareholding
24th Feb 20107:00 amRNSDirector/PDMR Shareholding
27th Nov 20097:00 amRNSHalf Yearly Report
23rd Oct 20097:00 amRNSTrading Update
23rd Jul 20092:37 pmRNSAGM Statement
30th Jun 20095:28 pmRNSPosting of Annual Report and Accounts
9th Jun 20093:08 pmRNSHolding(s) in Company
4th Jun 20097:00 amRNSFinal Results
16th Feb 20097:00 amRNSTrading Update
5th Jan 20097:00 amRNSChange of Adviser
19th Dec 20083:24 pmRNSDirectors Dealings
27th Nov 20087:00 amRNSInterim Results
18th Nov 20087:00 amRNSTrading Update
11th Nov 20087:00 amRNSChange of Nominated Adviser
8th Oct 200810:02 amRNSChange of Adviser Name
28th Jul 20083:17 pmRNSResult of AGM
28th Jul 20082:00 pmRNSAGM Statement
2nd Jul 20084:26 pmRNSDirectors' Dealings
1st Jul 20082:44 pmRNSFinal outcome of nuisance cla
6th Jun 200810:24 amRNSDividend Declaration
5th Jun 20087:00 amRNSFinal Results
25th Feb 20084:33 pmRNSDirector's Dealings
20th Dec 200711:28 amRNSDirector/PDMR Shareholding
27th Nov 200712:43 pmRNSDirector/PDMR Shareholding
27th Nov 20077:00 amRNSInterim Results
17th Aug 20078:25 amRNSAIM Rule 26
6th Aug 20079:47 amRNSChange of Name
31st Jul 20077:00 amRNSTotal Voting Rights
27th Jul 20073:46 pmRNSResult of AGM and Name Change
27th Jul 200712:41 pmRNSAGM Statement
6th Jul 200710:02 amRNSDirector's Dealings
7th Jun 200710:36 amRNSDirector's Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.